ScinoPharm Taiwan Ltd 2020 SR
The report highlights ScinoPharm Taiwan's 2020 sustainability performance, focusing on its role as a leading API supplier. Key achievements include a 13% increase in gross profit and significant waste reduction, with a 66% decrease in high-water-content waste liquid treated by third parties. The company invested NT$5,985,000 in solar panels to promote green energy. It maintains a strong focus on gender equality, with a 6:4 male-to-female ratio among senior managers. Additionally, the company exceeded legal requirements for employing people with disabilities by 30%.
Company: ScinoPharm Taiwan Ltd
Sector: Manufacturing
Country: Taiwan
Year: 2020
Type: SR
Pages: 123
Back to company
ScinoPharm Taiwan Ltd
Corporate Sustainability Report
The report highlights ScinoPharm Taiwan's 2020 sustainability performance, focusing on its role as a leading API supplier. Key achievements include a 13% increase in gross profit and significant waste reduction, with a 66% decrease in high-water-content waste liquid treated by third parties. The company invested NT$5,985,000 in solar panels to promote green energy. It maintains a strong focus on gender equality, with a 6:4 male-to-female ratio among senior managers. Additionally, the company exceeded legal requirements for employing people with disabilities by 30%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Sep 1, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees